BGB-102

• Description:

  BGB-102 (JNJ-26483327) is a kinase inhibitor targeting FLT3 and YES1 and an antagonist targeting EGFR and VEGFR3, which may be useful in the study of macular degeneration and diseases associated with genetic disorders and malformations.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  457.36

• Molecular Formula:

  C22H25BrN4O2

• Notes:

  Research use only, not for human use.

• Receptor:

  FLT | VEGFR | EGFR | Src

• CAS Number:

  807640-87-5